SynthesisHealth technology assessment (Winchester, England)2024

Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.

Beth Woods et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.